Ativan Tablets
Name: Ativan Tablets
Indications and Usage for Ativan Tablets
Ativan (lorazepam) is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.
The effectiveness of Ativan (lorazepam) in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
PRINCIPAL DISPLAY PANEL - 0.5 mg Bottle Label
NDC 0187-0063-01
Ativan®
(lorazepam)
0.5 mg
100 Tablets
CIV
SEALED
FOR YOUR
PROTECTION
Rx only
VALEANT
ATIVAN lorazepam tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0187-0063 | Route of Administration | ORAL | DEA Schedule | CIV | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | lorazepam (lorazepam) | lorazepam | 0.5 mg | |
Inactive Ingredients | Ingredient Name | Strength | lactose monohydrate | | MAGNESIUM STEARATE | | POLACRILIN POTASSIUM | | cellulose, microcrystalline | | |
Product Characteristics | Color | WHITE | Score | no score | Shape | PENTAGON (5 sided) (SHIELD SHAPE) | Size | 5mm | Flavor | | Imprint Code | A;BPI;63 | Contains | | |
Packaging | # | Item Code | Package Description | 1 | NDC:0187-0063-01 | 100 TABLET in 1 BOTTLE | 2 | NDC:0187-0063-50 | 500 TABLET in 1 BOTTLE | 3 | NDC:0187-0063-10 | 1000 TABLET in 1 BOTTLE | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | NDA | NDA017794 | 05/01/2013 | | |
ATIVAN lorazepam tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0187-0064 | Route of Administration | ORAL | DEA Schedule | CIV | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | lorazepam (lorazepam) | lorazepam | 1 mg | |
Inactive Ingredients | Ingredient Name | Strength | lactose monohydrate | | MAGNESIUM STEARATE | | POLACRILIN POTASSIUM | | cellulose, microcrystalline | | |
Product Characteristics | Color | WHITE | Score | 2 pieces | Shape | PENTAGON (5 sided) (SHIELD SHAPE) | Size | 6mm | Flavor | | Imprint Code | A;BPI;64 | Contains | | |
Packaging | # | Item Code | Package Description | 1 | NDC:0187-0064-01 | 100 TABLET in 1 BOTTLE | 2 | NDC:0187-0064-50 | 500 TABLET in 1 BOTTLE | 3 | NDC:0187-0064-10 | 1000 TABLET in 1 BOTTLE | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | NDA | NDA017794 | 05/01/2013 | | |
ATIVAN lorazepam tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0187-0065 | Route of Administration | ORAL | DEA Schedule | CIV | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | lorazepam (lorazepam) | lorazepam | 2 mg | |
Inactive Ingredients | Ingredient Name | Strength | lactose monohydrate | | MAGNESIUM STEARATE | | POLACRILIN POTASSIUM | | cellulose, microcrystalline | | |
Product Characteristics | Color | WHITE | Score | 2 pieces | Shape | PENTAGON (5 sided) (SHIELD SHAPE) | Size | 7mm | Flavor | | Imprint Code | A;2;BPI;65 | Contains | | |
Packaging | # | Item Code | Package Description | 1 | NDC:0187-0065-01 | 100 TABLET in 1 BOTTLE | 2 | NDC:0187-0065-50 | 500 TABLET in 1 BOTTLE | 3 | NDC:0187-0065-10 | 1000 TABLET in 1 BOTTLE | |
|
Marketing Information | Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date | NDA | NDA017794 | 05/01/2013 | | |
Labeler - Valeant Pharmaceuticals North America LLC (042230623) |
Establishment |
Name | Address | ID/FEI | Operations |
MEDA Manufacturing GmbH | | 329238187 | MANUFACTURE(0187-0063, 0187-0064, 0187-0065) |
Revised: 12/2016 Valeant Pharmaceuticals North America LLC